Antibodies
Login
Search   
Purified anti-Cdc25A-Phosphorylated (Ser17) Antibody
Purified anti-Cdc25A-Phosphorylated (Ser17) Antibody
620702 200 µl (20 Western blots) $350.00     

Product Details

Clone: Poly6207
Isotype: Rabbit IgG
Reactivity: Human, recognizes Ser17-phosphorylated Cdc25A
Immunogen: Modified peptide
Formulation: This antibody is provided in phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and 50% glycerol.
Preparation: The antibody was peptide-purified by affinity chromatography.
Storage & Handling: Upon receipt, store frozen at -20° C.
Application:

WB - Quality tested

Recommended Usage: Each lot of this antibody is quality control tested by Western blotting. Western blotting, suggested working dilution(s): Use 10 μl per 5 ml antibody dilution buffer for each mini-gel. It is recommended that the reagent be titrated for optimal performance for each application.
COA:
Enter Lot#:   
Hela cells were treated with
Hela cells were treated with 300 µM mimosine for 16 hrs, then placed in complete media (lane 1) or media containing 200 ng/ml nocodazole (lane 2) for an additional 18hrs. Nuclear extract was resolved by electrophoresis, transferred to nitrocellulose, and probed with rabbit polyclonal antibody reactive against phosphorylated Cdc25A (Ser17). Proteins were visualized using a donkey anti-rabbit secondary conjugated to HRP and a chemiluminescence detection system.


Compare all formats



Description: Cdc25A (also know as M-phase inducer phosphatase 1 and dual specificity phosphatase Cdc25A) is a 65 kD MPI phosphatase containing a rhodanese domain. This nuclear protein functions as a dosage-dependent inducer in mitotic control required for the progression of cell cycle. Cdc25A activates Cdc2 by dephosphorylation, dephosphorylates CDK2 in complex with cyclin E. Cdc25A is timulated by cyclins B, downregulated by Chk1 and Cds1/Chk2 phosphorylation. This phosphatase has been shown to interact with Cdc2, cyclin B, Cdk2, Chk1, and Chk2. The Poly6207 antibody recognizes phosphorylated human Cdc25A (Ser17) and has been shown to be useful for Western blotting.
Other Names: M-phase inducer phosphatase 1, Dual specificity phosphatase Cdc25A
Structure: MPI phosphatase, rhodanese domain; 65 kD
Distribution: Nuclear
Function: Dosage-dependent inducer of mitotic control required for progression of cell cycle. Activates Cdc2 by dephosphorylation; dephosphorylates CDK2 in complex with cyclin E
Regulation: Stimulated by cyclin B, downregulated by Chk1 and Cds1/Chk2 phosphorylation
Modification: Phosphorylation
Interaction: Cdc2, cyclin B,Cdk2,Chk1,Chk2
Antigen
References:
1. Galaktionov K, et al. 1991. Cell. 67:1181.
2. Jinno S, et al. 1994. EMBO J. 13:1549.
3. Ducruet A, et al. 2003. J. Biol. Chem. 278:31838.
4. Sorensen C, et al. 2003. Cancer Cell. 3:247.
GeneID: 993
Latest Publications: View the latest Cdc25A-Phosphorylated (Ser17) articles on HighwirePress.com
UniProt: View information about Cdc25A-Phosphorylated (Ser17) on UniProt.org
Keywords: Purified anti-Cdc25A-Phosphorylated (Ser17), Poly6207, Purified, M-phase inducer phosphatase 1, Dual specificity phosphatase Cdc25A, Human, recognizes Ser17-phosphorylated Cdc25A, Immunology, Antibodies
Related Products

DescriptionCloneApplications
HRP Donkey anti-rabbit IgG (minimal x-reactivity)Poly4064ELISA, IHC, WB

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/terms). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.
x
Compare Data Across All Formats
This data display is provided for general comparisons between formats. Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors. If you need assistance with selecting the best format contact our expert technical support team.

  • Purified anti-Cdc25A-Phosphorylated (Ser17)
    Hela cells were treated with

    Hela cells were treated with 300 µM mimosine for 16 hrs, then placed in complete media (lane 1) or media containing 200 ng/ml nocodazole (lane 2) for an additional 18hrs. Nuclear extract was resolved by electrophoresis, transferred to nitrocellulose, and probed with rabbit polyclonal antibody reactive against phosphorylated Cdc25A (Ser17). Proteins were visualized using a donkey anti-rabbit secondary conjugated to HRP and a chemiluminescence detection system.

x
Copyright © 2011 BioLegend, Inc. All rights reserved.